ORTOMA AB B (F:82Y) — Market Cap & Net Worth
Market Cap & Net Worth: ORTOMA AB B (82Y)
ORTOMA AB B (F:82Y) has a market capitalization of $32.05 Million (€27.42 Million) as of August 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #23491 globally and #2051 in its home market, demonstrating a -10.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ORTOMA AB B's stock price €0.64 by its total outstanding shares 42836477 (42.84 Million). See ORTOMA AB B capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
ORTOMA AB B Market Cap History: 2021 to 2026
ORTOMA AB B's market capitalization history from 2021 to 2026. Data shows change from $124.70 Million to $32.05 Million (-23.05% CAGR).
ORTOMA AB B Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ORTOMA AB B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.94x
ORTOMA AB B's market cap is 0.94 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $43.07 Million | $38.14 Million | -$21.87 Million | 1.13x | N/A |
| 2024 | $37.56 Million | $49.11 Million | -$11.63 Million | 0.76x | N/A |
| 2025 | $60.85 Million | $64.64 Million | -$19.19 Million | 0.94x | N/A |
Competitor Companies of 82Y by Market Capitalization
Companies near ORTOMA AB B in the global market cap rankings as of August 4, 2026.
Key companies related to ORTOMA AB B by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #113 globally with a market cap of $186.27 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #180 globally with a market cap of $130.57 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #239 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #113 | Abbott Laboratories | NYSE:ABT | $186.27 Billion | $107.12 |
| #180 | Stryker Corporation | NYSE:SYK | $130.57 Billion | $341.20 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #239 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $86.68 |
ORTOMA AB B Historical Marketcap From 2021 to 2026
Between 2021 and today, ORTOMA AB B's market cap moved from $124.70 Million to $ 32.05 Million, with a yearly change of -23.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €32.05 Million | -47.33% |
| 2025 | €60.85 Million | +62.00% |
| 2024 | €37.56 Million | -12.79% |
| 2023 | €43.07 Million | -16.10% |
| 2022 | €51.33 Million | -58.84% |
| 2021 | €124.70 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of ORTOMA AB B was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.05 Million USD |
| MoneyControl | $32.05 Million USD |
| MarketWatch | $32.05 Million USD |
| marketcap.company | $32.05 Million USD |
| Reuters | $32.05 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ORTOMA AB B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more